Playing defense, Roche loses megafranchise gambit as Gazyva flunks head-to-head with Rituxan
A few weeks ago, Roche CEO Severin Schwan told reporters at Reuters that he was sleeping much better at night. The pharma giant reported …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
